Skip to main content
Log in

The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited endocrine cancer syndrome characterised by parathyroid, pancreas, and anterior pituitary tumors. The disease responsible gene, MEN1, was identified in 1997 and localizes to chromosome 11q13 in a minimal 600 kb interval between PYGM and D11S449 loci. About 10–20% of MEN1 patients do not have any mutation in the coding region and/or in the exon-intron junctions of the MEN1 gene. In this case, familial haplotype analysis of the 11q13 region, in at least two generations of affected members, is the only possible genetic ascertainment of the disease. We performed a microsatellite haplotype analysis at 11q13 region in 8 living and 1 deceased member of a MEN1 Italian family without any detected germline mutation of the MEN1 gene. The application of forensic techniques for ancient DNA analysis made it possible to identify the familial disease-associated haplotype and demonstrated that MEN1 disease haplotype family history can be reconstructed even when one or more family members are deceased. Identification of MEN1 disease haplotype is helpful in the clinical management of patients and relatives in families without any mutation of the MEN1 gene. Genetic screening allows the identification of individuals who are at risk before the development of clinical symptoms, limiting invasive annual cancer surveillance only to genetically positive individuals and making it possible to avoid further clinical screenings in non-carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658–71.

    Article  PubMed  CAS  Google Scholar 

  2. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 2005, 5: 367–75.

    Article  PubMed  CAS  Google Scholar 

  3. Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol 2005, 89: 143–50.

    Article  PubMed  Google Scholar 

  4. Agarwal SK, Lee Burns A, Sukhodolets KE, et al. Molecular pathology of the MEN1 gene. Ann NY Acad Sci 2004, 1014: 189–98.

    Article  PubMed  CAS  Google Scholar 

  5. Bordi C. Multiple endocrine neoplasia (MEN)-associated tumours. Dig Liver Dis 2004, 36 (Suppl 1): S31–4.

    Article  PubMed  Google Scholar 

  6. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988, 332: 85–7.

    Article  PubMed  CAS  Google Scholar 

  7. Friedman E, Sakaguchi K, Bale AE, et al. Clonality of parathyroid tumours in familial multiple endocrine neoplasia type 1. N Engl J Med 1989, 321: 213–8.

    Article  PubMed  CAS  Google Scholar 

  8. Thakker RV, Bouloux P, Wooding C, et al. Association of parathyroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989, 321: 218–24.

    Article  PubMed  CAS  Google Scholar 

  9. Thakker RV. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol 1993, 39: 1–14.

    Article  Google Scholar 

  10. Byström C, Larsson C, Blomberg C, et al. Localisation of the MEN1 gene to a small region within chromosome 11q13 by delection mapping in tumors. Proc Nat Acad Sci U S A 1990, 87: 1968–72.

    Article  Google Scholar 

  11. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276: 404–7.

    Article  PubMed  CAS  Google Scholar 

  12. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997, 6: 1169–75.

    Article  PubMed  CAS  Google Scholar 

  13. Giraud S, Zhang CX, Serova-Sinilnikova O, et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 1998, 63: 455–67.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Teh BT, Kytölä S, Farnebo F, et al. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998, 83: 2621–6.

    PubMed  CAS  Google Scholar 

  15. Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases. Hum Mutat 1999, 13: 54–60.

    Article  PubMed  CAS  Google Scholar 

  16. Hai N, Aoki N, Matsuda A, Mori T, Kosugi S. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1). EurJ Endocrinol 1999, 141: 475–80.

    Article  CAS  Google Scholar 

  17. Morelli A, Falchetti A, Martineti V, et al. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 2000, 142: 131–7.

    Article  PubMed  CAS  Google Scholar 

  18. Gagel RF, Marx SJ. Multiple Endocrine Neoplasia. In: Larsen PR, Kronenberg H, Melmed S Polonsky K, editors. Williams Textbook of Endocrinology 10th Ed. Orlando: WB Saunders & Company. 2002, 1717–62.

    Google Scholar 

  19. Bassett JH, Forbes SA, Pannett AA, et al. Characterisation of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998, 62: 232–44.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Lemmens I, Van de Ven WJ, Kas K, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 1997, 6: 1177–83.

    Article  CAS  Google Scholar 

  21. Lubensky IA, Debelenko LV, Zhuang Z, et al. Allelic deletions on chromosome 11q13 in multiple tumours from individual MEN1 patients. Cancer Res 1996, 56: 5272–8.

    PubMed  CAS  Google Scholar 

  22. Emmert-Buck MR, Lubensky IA, Dong Q, et al. Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumour loss of heterozygosityanalysis. Cancer Res 1997, 57: 1855–8.

    PubMed  CAS  Google Scholar 

  23. Nakamura Y, Larsson C, Julier C, et al. Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet 1989, 44: 51–5.

    Google Scholar 

  24. Petty EM, Green JS, Marx SJ, Taggart RT, Farid N, Bale AE. Mapping the gene for the hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 1994, 54: 1060–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  25. Giraud S, Choplin H, Teh BT, et al. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab 1997, 82: 3487–92.

    PubMed  CAS  Google Scholar 

  26. Valdes N, Alvarez V, Diaz-Cadorniga F, et al. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases. Anticancer Res 1998, 18: 2685–9.

    PubMed  CAS  Google Scholar 

  27. Pääbo S, Poinar H, Serre D, et al. Genetic analyses from ancient DNA. Ann Rev Genet 2004, 38: 645–79.

    Article  PubMed  CAS  Google Scholar 

  28. Cooper A, Poinar HN. Ancient DNA: do it right or not at all. Science 2000, 289: 1139.

    Article  PubMed  CAS  Google Scholar 

  29. Hofreiter M, Serre D, Poinar HN, Kuch M, Pääbo S. Ancient DNA. Nat Rev Genet 2001, 2: 353–9.

    Article  PubMed  CAS  Google Scholar 

  30. Krings M, Stone A, Schmitz RW, Krainitzki H, Stoneking M, Pääbo S. Neanderthal DNA sequences and the origin of modern humans. Cell 1997, 90: 19–30.

    Article  PubMed  CAS  Google Scholar 

  31. Ferolla P, Falchetti A, Filosso P, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90: 2603–9.

    Article  PubMed  CAS  Google Scholar 

  32. Guru SC, Agarwal SK, Manickam P, et al. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res 1997, 7: 725–35.

    PubMed Central  PubMed  CAS  Google Scholar 

  33. Caramelli D, Lalueza-Fox C, Vernesi C, et al. Evidence for a genetic discontinuity between Neandertals and 24,000-year-old anatomically modern Europeans. Proc Natl Acad Sci U S A 2003, 100: 6593–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  34. Noonan JP, Hofreiter M, Smith D, et al. Genomic sequencing of Pleistocene cave bears. Science 2005, 309: 597–9.

    Article  PubMed  CAS  Google Scholar 

  35. Bogenhagen D, Clayton DA. The number of mitochondrial deoxyribonucleic acid genomes in mouse L and human HeLa cells. Quantitative isolation of mitochondrial deoxyribonucleic acid. J Biol Chem 1974, 249: 7991–5.

    CAS  Google Scholar 

  36. Moraes CT. What regulates mitochondrial DNA copy number in animal cells? Trends Genet 2001, 17: 199–205.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. L. Brandi MD, PhD.

Additional information

Both authors contributed equally to the manuscript

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marini, F., Sala, S.C., Falchetti, A. et al. The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis. J Endocrinol Invest 31, 905–909 (2008). https://doi.org/10.1007/BF03346440

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346440

Key-words

Navigation